Physician profile
William Salvatore Scialla
NPI 1881803344
$554.31
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $87.95 · 2021: $11.92 · 2022: $141.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $126.78 | 2019-2022 | |
| Pfizer INC. | $63.76 | 2019-2020 | |
| Genentech USA, INC. | $46.45 | 2019-2020 | |
| Celgene Corporation | $46.26 | 2019 | |
| Janssen Biotech, INC. | $45.82 | 2019-2020 | |
| Beigene USA, INC. | $27.14 | 2022 | |
| Alexion Pharmaceuticals, INC. | $26.60 | 2019 | |
| Tactile Systems Technology INC | $20.83 | 2020 | |
| Astellas Pharma US INC | $19.23 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $17.43 | 2019 | |
| Eisai INC. | $17.04 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.82 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.37 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $14.01 | 2019 | |
| Amgen INC. | $13.72 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.35 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.78 | 2019 | |
| Gilead Sciences, INC. | $11.92 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Scialla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.